Sign in
8-K

Current Report

CRISPR Therapeutics AG Filed Acc 0001193125-20-018422

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d844371d8k.htm…